US FDA approves Tonix Pharma's drug to manage pain related to chronic condition
Aug 15 (Reuters) - The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals' TNXP.O drug to manage pain related to a type of chronic condition, the company said on Friday. (Reporting by Siddhi Mahatole and Sriparna Roy in Bengaluru; Editing by Vijay Kishore and Shreya Biswas) ((siddhi.mahatole@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview